Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells

Blood

Volumn 95, Issue 8, 2000, Pages 2484-2490

  Arpinati, Mario ^a   Green, Cherie L ^a   Heimfeld, Shelly ^a   Heuser, Jill E ^a   Anasetti, Claudio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; CELL COUNT; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MICROFLUOROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; TH2 CELL;

EID: 0034655607     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.8.2484.008k01_2484_2490     Document Type: Review

References (47)

1. Bensinger WI, Cliff RA, Anasetti C, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells. 1996; 14:90.
2. Russell NH, Gratwohl A, Schmitz N. Developments in allogeneic peripheral blood progenitor cell transplantation. Br J Haematol. 1998;103: 594.
3. Nemunaitis J. Cytokine-mobilized peripheral blood progenitor cells. Semin Oncol. 1996;23(no. 2, suppl 4):9.
4. Dreger P, Suttorp M, Haferlach L, Loffler H, Schmitz N, Schrogens W. Allogeneic granulocyte-colony stimulating factor mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood. 1993;81:1404.
5. Bensinger W, Weaver C, Appelbaum F, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor. Blood. 1995;85:1655.
6. Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood. 1995;85: 1659.
7. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor calls mobilized by filgrastim (granulocyte colony-stimulating factor). Blood, 1995;85:1666.
8. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998; 339:1186.
9. Beelen D, Ottinger H, Elmaagachli A, et al. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical siblings or alternative family donors in patients with hematological malignancies: a prospective comparison on clinical outcome, immune reconstitution and hematopoietic chimerism. Blood. 1997;90:4725.
10. Storek J, Gooley T, Siadak M, et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood. 1997;90:4705.
11. Champlin R, Schmitz N, Horowitz MM. Allogeneic blood stem cells (BSC) versus bone marrow transplantation (BMT): improved leukemia-free survival in high risk but not low risk patients [abstract]. Blood. 1998;92(suppl 1):657.
12. Pan L, Delmonte J, Jalonen C, Ferrara J. Pretreatment of donor mice with granulocyte-colony stimulating factor polarizes T-lymphocytes towards type-2 cytokine production and reduced severity of experimental graft-versus-host-disease. Blood. 1995;86:4422.
13. Zeng D, Dejbakshn-Jones S, Strober S. Granulocyte-colony stimulating factor reduced the capacity of blood mononuclear cells to induce graft versus host disease: impact on blood progenitor cell transplantation. Blood. 1997;90:453.
14. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature. 1996;383: 787.
15. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183.
16. Pulendran B, Smith JL, Caspary G, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A. 1999;96:1036.
17. Maldonado-Lopez R, De Smedt T, Michel P, et al. CD8α+ and CD8α-subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med. 1999;189:587.
18. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245.
19. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 1992;360:258.
20. + bone marrow precursors cultured with c-kit ligand, granulocyte macrophage-colony stimulating factor, and TNF-α. J Immunol. 1995;154:5851.
21. + cells identifies immuno-competent committed precursors of macrophages and dendritic cells. Blood. 1998;91:3892.
22. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med. 1994;180:83.
23. Grouard G, Durand I, Filgueira L, Banchereau J, Liu YJ. Dendritic cells capable of stimulating T cells in germinal centres. Nature. 1996;384:364.
24. + T cells. J Immunol. 1995;10:5071.
25. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 1996;184:747.
26. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 1994;82:487.
27. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin-3 and CD40-ligand. J Exp Med. 1997;185: 1101.
28. Olweus J, BilMansour A, Warnke R, et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A. 1997; 94:12,551.
29. Cella M, Jarrossay D, Facchetti F, et al. Plasmocytoid monocytes migrate to inflamed lymph nodes and produce large amounts ol type I interferon. Nat Med. 1999;5:919.
30. + peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol. 1999; 163:3250.
31. Robinson SP, Parterson S, English N, Davies D, Knight SC, Reid CDL. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol. 1999;29:2769.
32. Bruno L, Res P, Dessing M, Cella M, Spits H. Identification of a committed T cell precursor population in adult human peripheral blood. J Exp Med. 1997;185:875.
33. Prosper F, Stroncek D, McCarthy JB, Verfaillie CM. Mobilization and homing of peripheral blood progenitors is related to reversible down regulation of α4β1 integrin expression and function. J Clin Invest. 1998;101:2456.
34. + donor T cells fail to induce experimental acute graft-versus-host-disease. J Immunol. 1995;155:585.
35. Krenger W, Cooke KR, Crawford JM, et al. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease. Transplantation. 1996;15: 1278.
36. Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood. 1994;84:3540.
37. Imami N, Brookes PA, Lombardi G, et al. Association between interleukin-4 producing T lymphocyte frequencies and reduced risk of graft-versus-host disease. Transplantation. 1998;65:979.
38. Sorg RV, Kogler G, Wernet P. Identification of cord blood dendritic cells as an immature CD11c population. Blood. 1999;93:2302.
39. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999;285:412.
40. Steptoe RJ, Thomson AW. Dendritic cells and tolerance induction. Clin Exp Immunol. 1996;105: 397.
41. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW, GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation. 1995;60:1366.
42. Lu L, Li W, Fu F, et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997;64:1808.
43. Lee WC, Zhong C, Qian S, et al. Phenotype, function and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β. Transplantation. 1998;66:1810.
44. Richters CD, Van Gelderop E, Du Pont JS, Hoekstra MJ, Kreis RW, Kamperdijk EWA. Migration of dendritic cells to the draining lymph nodes after allogeneic or congeneic rat skin transplantation. Transplantation. 1999;67:828.
45. + T cell-mediated graft rejection. Eur J Immunol. 1997;27:1663.
46. Li XC, Zand MS, Li Y, Zheng XX, Strom TB. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol. 1998;161:2241.
47. He XY, Chen J, Verma N, Plain K, Tran G, Hall BM. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses. Transplantation. 1998;65: 1145.